Accessibility Menu
Getinge Ab (publ) logo

Getinge Ab (publ)(OTC) GNGBY

Market Cap$6.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-4%
5 Year-35%
1 Year+19%
1 Month+1%
$25.55
+1.39%
+0.35Today
Getinge Ab (publ) last closing stock price
MetricPriceDate
Last closeUSD 25.202026-09-02
Getinge Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.09%USD 25.742026-08-26
1 month+0.6%USD 25.052026-08-03
3 month+21.62%USD 20.722026-06-04
Year to date+9.15%USD 23.092025-12-31
1 year+18.9%USD 21.192025-09-02
3 year+57.06%USD 16.042023-09-01
5 year-35%USD 38.772021-09-03
Since inception-4.33%USD 26.342011-06-23

Getinge Ab (publ) Financials at a Glance

Market Cap

$6.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 34.12B

Net Income (TTM)

SEK 2.67B

EPS (TTM)

$1.05

P/E Ratio

24.05

Dividend

$0.51

Beta (Volatility)

0.89 (Low)

Price

$25.55

Volume

499

Open

$25.55

Previous Close

$25.55

Daily Range

$25.55 - $25.55

52-Week Range

$18.99 - $25.98

Estimated Earnings Date

Oct 20, 2026

GNGBY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Getinge Ab (publ)

Getinge AB (publ) is a leading global medical technology provider, specializing in comprehensive products and solutions for operating rooms, intensive care units, and sterilization departments. The company operates through three segments: Acute Care Therapies, Life Science, and Surgical Workflows, offering a diverse range of advanced medical devices and solutions.

Products and Services
  • Advanced transfer systems and sterilizers for sterile environments
  • Bioreactors and perfusion systems for life sciences
  • Anesthesia machines and patient monitoring systems for acute care
Growth Outlook
  • Revenue growth of 12.6% year-over-year in Q2 2026
  • Strong demand in the life sciences segment driving innovation
  • Expansion into emerging markets expected to enhance market share
Financial Highlights
  • Net income of SEK 841 million in Q2 2026, up from SEK 401 million in Q1 2026
  • Operating income margin improved to 16.1% in Q2 2026
  • Trailing twelve months (TTM) revenue of SEK 33.4 billion, reflecting consistent growth
Getinge AB (publ) has established itself as a key player in the medical technology industry, with a robust portfolio that addresses critical healthcare needs. The company's focus on innovation and quality positions it well for future growth, particularly in the life sciences and acute care segments. Recent financial performance indicates a positive trajectory, with significant revenue growth and improved profitability metrics. The strategic expansion into emerging markets further enhances the potential for sustained growth, making Getinge an intriguing option for investors interested in the healthcare sector.
AI Generated • Aug 29, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

11,758

CEO

Mattias Sven Perjos

Website

www.getinge.com

Headquarters

Gothenburg, VG 417 56, SE

GNGBY Financials

Key Financial Metrics (TTM)

Gross Margin

47.57%

Operating Margin

13.56%

Net Income Margin

7.82%

Return on Equity

8.88%

Return on Capital

9.40%

Return on Assets

4.66%

Earnings Yield

4.16%

Dividend Yield

2.03%

Payout Ratio

49.03%

Stock Overview

Market Cap

$6.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

254.15M

Volume

499

Avg. Volume

1.78K

Financials (TTM)

Gross Profit

SEK 15.91B

Operating Income

SEK 4.45B

EBITDA

SEK 6.59B

Operating Cash Flow

SEK 5.02B

Capital Expenditure

-SEK 1.23B

Free Cash Flow

SEK 3.78B

Cash & ST Invst.

SEK 2.05B

Total Debt

SEK 11.10B

Getinge Ab (publ) Performance Analysis

Getinge Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 2,795,681,619-11.3%
20232023-12-31SEK 2,998,037,6777.2%
20242024-12-31SEK 3,287,608,5069.7%
20252025-12-31SEK 3,565,533,3388.5%
Getinge Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-1.6%
Q42025-12-3125.7%
Q12026-03-31-26.9%
Q22026-06-3012.6%
Getinge Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK 0.90-28.9%
20232023-12-31SEK 0.83-7.7%
20242024-12-31SEK 0.57-31.8%
20252025-12-31SEK 0.8548.6%
Getinge Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-306.8%
Q42025-12-3157.1%
Q12026-03-31-54.3%
Q22026-06-30110.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SEK 8.38B

+1.7%

Gross Profit

SEK 4.42B

+12.1%

Gross Margin

52.69%

N/A

Market Cap

$6.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$528.52K

N/A

Employees

12,118

N/A

Net Income

SEK 841.00M

+60.5%

EBITDA

SEK 1.86B

+31.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SEK 2.05B

+5.5%

Total Debt

SEK 11.10B

-0.6%

Accounts Receivable

SEK 6.88B

-1.7%

Inventory

SEK 6.84B

+0.7%

Long Term Debt

SEK 9.09B

+1.3%

Short Term Debt

SEK 2.01B

-8.3%

Return on Assets

4.66%

N/A

Return on Invested Capital

10.24%

N/A

Free Cash Flow

SEK 995.00M

+96.6%

Operating Cash Flow

SEK 1.29B

+53.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NARIInari Medical, Inc.
$79.97+0.00%
BRKRBruker Corporation
$59.41+0.66%
MASIMasimo Corporation
$179.95+0.00%
TMDXTransMedics Group, Inc.
$86.98+3.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About GNGBY

What is the current price of Getinge Ab (publ)?

Getinge Ab (publ) is trading at $25.55 per share.

What is the 52-week range for Getinge Ab (publ)?

Over the past 52 weeks, Getinge Ab (publ) has traded between $18.99 and $25.98.

How much debt does Getinge Ab (publ) have?

As of the most recent reporting period, Getinge Ab (publ) reported total debt of SEK 1.15B.

How much cash does Getinge Ab (publ) have on hand?

Getinge Ab (publ) reported SEK 212.02M in cash and cash equivalents in its most recent financial results.

What is Getinge Ab (publ)’s dividend yield?

Getinge Ab (publ) currently has a dividend yield of 2.03%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services